Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7

1 p.

Autores:
Prada Prada, Sergio Alfonso
Flórez Castillo, Johanna-Marcela
Farfán García, Ana Elvira
Guzmán, Fanny
Hernández Peñaranda, Indira Paola
Tipo de recurso:
Article of journal
Fecha de publicación:
2020
Institución:
Universidad de Santander
Repositorio:
Repositorio Universidad de Santander
Idioma:
eng
OAI Identifier:
oai:repositorio.udes.edu.co:001/4693
Acceso en línea:
https://doi.org/10.1371/journal. pone.0229019
https://repositorio.udes.edu.co/handle/001/4693
Palabra clave:
Antimicrobial activity
Ib-M peptides
Escherichia coli
Antibiotics
Rights
restrictedAccess
License
Derechos Reservados - Prada-Prada et al., 2020
id RUDES2_742b649f6dcd9ba2491c97f5c3f209f7
oai_identifier_str oai:repositorio.udes.edu.co:001/4693
network_acronym_str RUDES2
network_name_str Repositorio Universidad de Santander
repository_id_str
dc.title.eng.fl_str_mv Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7
title Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7
spellingShingle Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7
Antimicrobial activity
Ib-M peptides
Escherichia coli
Antibiotics
title_short Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7
title_full Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7
title_fullStr Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7
title_full_unstemmed Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7
title_sort Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7
dc.creator.fl_str_mv Prada Prada, Sergio Alfonso
Flórez Castillo, Johanna-Marcela
Farfán García, Ana Elvira
Guzmán, Fanny
Hernández Peñaranda, Indira Paola
dc.contributor.author.spa.fl_str_mv Prada Prada, Sergio Alfonso
Flórez Castillo, Johanna-Marcela
Farfán García, Ana Elvira
Guzmán, Fanny
Hernández Peñaranda, Indira Paola
dc.contributor.corporatename.spa.fl_str_mv Universidad de Santander
dc.contributor.editor.spa.fl_str_mv Iddya Karunasagar, Nitte University, INDIA
dc.subject.proposal.eng.fl_str_mv Antimicrobial activity
Ib-M peptides
Escherichia coli
Antibiotics
topic Antimicrobial activity
Ib-M peptides
Escherichia coli
Antibiotics
description 1 p.
publishDate 2020
dc.date.accessioned.spa.fl_str_mv 2020-08-20T14:24:26Z
dc.date.available.spa.fl_str_mv 2020-08-20T14:24:26Z
dc.date.issued.spa.fl_str_mv 2020-02-13
dc.type.spa.fl_str_mv Artículo de revista
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/ART
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.citation.eng.fl_str_mv Prada-Prada S, Flórez-Castillo J, Farfán- García A, Guzmán F, Hernández-Peñaranda I (2020) Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7. PLoS ONE 15 (2): e0229019.
dc.identifier.doi.eng.fl_str_mv https://doi.org/10.1371/journal. pone.0229019
dc.identifier.uri.spa.fl_str_mv https://repositorio.udes.edu.co/handle/001/4693
identifier_str_mv Prada-Prada S, Flórez-Castillo J, Farfán- García A, Guzmán F, Hernández-Peñaranda I (2020) Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7. PLoS ONE 15 (2): e0229019.
url https://doi.org/10.1371/journal. pone.0229019
https://repositorio.udes.edu.co/handle/001/4693
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartof.eng.fl_str_mv Plos One
dc.relation.ispartofseries.eng.fl_str_mv PLOS ONE;February 13, 2020
dc.rights.spa.fl_str_mv Derechos Reservados - Prada-Prada et al., 2020
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_16ec
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/restrictedAccess
dc.rights.creativecommons.spa.fl_str_mv Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc/4.0/
rights_invalid_str_mv Derechos Reservados - Prada-Prada et al., 2020
Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
https://creativecommons.org/licenses/by-nc/4.0/
http://purl.org/coar/access_right/c_16ec
eu_rights_str_mv restrictedAccess
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.eng.fl_str_mv San Francisco : Plos One, 2020.
dc.source.eng.fl_str_mv https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0229019
institution Universidad de Santander
bitstream.url.fl_str_mv https://repositorio.udes.edu.co/bitstreams/829e25f5-797a-43e8-a3d1-8f6dd74054e9/download
https://repositorio.udes.edu.co/bitstreams/dd0d2cb8-f643-407e-8b6a-5c9e56ca6fb5/download
https://repositorio.udes.edu.co/bitstreams/fc3990fb-6fca-4869-9e35-6adc6cee0a31/download
https://repositorio.udes.edu.co/bitstreams/19fc0e40-9afb-4379-ab6f-df354a4bb255/download
bitstream.checksum.fl_str_mv 831e6040b97206e95bf2fdb8ceab039f
38d94cf55aa1bf2dac1a736ac45c881c
5dbe86c1111d64f45ba435df98fdc825
44d76a72a0ed324a3672a720c653fb3f
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Universidad de Santander
repository.mail.fl_str_mv soporte@metabiblioteca.com
_version_ 1818101364724596736
spelling Prada Prada, Sergio Alfonsocc945093-702a-4e7e-b598-17852200db11-1Flórez Castillo, Johanna-Marcelae5b9135c-adb9-4f3f-adf9-eae7cd9e6abf-1Farfán García, Ana Elvira74472815-bd1a-4bf4-932b-0264dd209268-1Guzmán, Fanny0ea45d23-51b8-4cbd-9a49-4283f773574d-1Hernández Peñaranda, Indira Paolaebe71324-2be9-45d1-9cfa-eef589289ef3-1Universidad de SantanderIddya Karunasagar, Nitte University, INDIA2020-08-20T14:24:26Z2020-08-20T14:24:26Z2020-02-131 p.El desarrollo de nuevos péptidos antimicrobianos se ha convertido en una alternativa atractiva a los antibióticos convencionales debido a las crecientes tasas de resistencia a los fármacos microbianos. Ib-M corresponde a una familia de péptidos sintéticos catiónicos, de 20 aminoácidos de longitud, que han mostrado efecto inhibidor frente a la cepa no patógena Escherichia coli K-12. Este trabajo evaluó el potencial antimicrobiano de los péptidos Ib-M contra el E patógeno . coli O157: H7 utilizando una cepa de referencia y un aislado clínico. Los péptidos Ib-M mostraron actividad antibacteriana contra ambas cepas de E . coliO157: H7; la concentración mínima inhibitoria de los péptidos Ib-M osciló entre 1,6 y 12,5 µM y la concentración bactericida mínima osciló entre 3,7 y 22,9 µM, siendo Ib-M1 e Ib-M2 los péptidos que presentaron mayor efecto inhibidor. El ensayo de cinética de eliminación del tiempo mostró una reducción de la población bacteriana en más del 95% después de 4 horas de exposición a 1xMIC de Ib-M1. Se observó una baja citotoxicidad en células VERO con una concentración citotóxica del 50% en el rango de 197,5 a más de 400 μM. Todos los péptidos mostraron una estructura aleatoria en ambientes hidrófilos, excepto Ib-M1, y todos ellos pasaron a una estructura α-helicoidal cuando se incrementó la hidrofobicidad del medio. En conclusión, estos hallazgos apoyan el efecto antimicrobiano in vitro de los péptidos Ib-M contra las bacterias patógenas.E . coli O157: H7 y resultan ser moléculas prometedoras para el desarrollo de nuevas alternativas terapéuticas.The development of new antimicrobial peptides has become an attractive alternative to conventional antibiotics due to the increasing rates of microbial drug resistance. Ib-M corresponds to a family of cationic synthetic peptides, 20 amino acids in length, that have shown inhibitory effect against the non-pathogenic strain Escherichia coli K-12. This work evaluated the antimicrobial potential of Ib-M peptides against the pathogenic E. coli O157: H7 using a reference strain and a clinical isolate. The Ib-M peptides showed antibacterial activity against both strains of E. coli O157: H7; the minimum inhibitory concentration of Ib-M peptides ranged from 1.6 to 12.5 μM and the minimum bactericidal concentration ranged from 3.7 to 22.9 μM, being Ib-M1 and Ib-M2 the peptides that presented the highest inhibitory effect. Time-kill kinetics assay showed a reduction of the bacterial population by more than 95% after 4 hours of exposure to 1xMIC of Ib-M1. Low cytotoxicity was observed in VERO cells with 50% cytotoxic concentration in the range from 197.5 to more than 400 μM. All peptides showed a random structure in hydrophilic environments, except Ib-M1, and all of them transitioned to an α-helical structure when the hydrophobicity of the medium was increased. In conclusion, these findings support the in vitro antimicrobial effect of Ib-M peptides against the pathogenic bacteria E. coli O157: H7 and prove to be promising molecules for the development of new therapeutic alternatives.Ej. 1application/pdfPrada-Prada S, Flórez-Castillo J, Farfán- García A, Guzmán F, Hernández-Peñaranda I (2020) Antimicrobial activity of Ib-M peptides against Escherichia coli O157: H7. PLoS ONE 15 (2): e0229019.https://doi.org/10.1371/journal. pone.0229019https://repositorio.udes.edu.co/handle/001/4693engSan Francisco : Plos One, 2020.Plos OnePLOS ONE;February 13, 2020Derechos Reservados - Prada-Prada et al., 2020info:eu-repo/semantics/restrictedAccessAtribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/http://purl.org/coar/access_right/c_16echttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0229019Antimicrobial activityIb-M peptidesEscherichia coliAntibioticsAntimicrobial activity of Ib-M peptides against Escherichia coli O157: H7Artículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85PublicationORIGINALAntimicrobial activity of Ib-M peptides against Escherichia coli O157.H7.pdfAntimicrobial activity of Ib-M peptides against Escherichia coli O157.H7.pdfapplication/pdf300103https://repositorio.udes.edu.co/bitstreams/829e25f5-797a-43e8-a3d1-8f6dd74054e9/download831e6040b97206e95bf2fdb8ceab039fMD51LICENSElicense.txtlicense.txttext/plain; charset=utf-859https://repositorio.udes.edu.co/bitstreams/dd0d2cb8-f643-407e-8b6a-5c9e56ca6fb5/download38d94cf55aa1bf2dac1a736ac45c881cMD52TEXTAntimicrobial activity of Ib-M peptides against Escherichia coli O157.H7.pdf.txtAntimicrobial activity of Ib-M peptides against Escherichia coli O157.H7.pdf.txtExtracted texttext/plain5https://repositorio.udes.edu.co/bitstreams/fc3990fb-6fca-4869-9e35-6adc6cee0a31/download5dbe86c1111d64f45ba435df98fdc825MD53THUMBNAILAntimicrobial activity of Ib-M peptides against Escherichia coli O157.H7.pdf.jpgAntimicrobial activity of Ib-M peptides against Escherichia coli O157.H7.pdf.jpgGenerated Thumbnailimage/jpeg11775https://repositorio.udes.edu.co/bitstreams/19fc0e40-9afb-4379-ab6f-df354a4bb255/download44d76a72a0ed324a3672a720c653fb3fMD54001/4693oai:repositorio.udes.edu.co:001/46932023-10-11 09:08:08.914https://creativecommons.org/licenses/by-nc/4.0/Derechos Reservados - Prada-Prada et al., 2020https://repositorio.udes.edu.coRepositorio Universidad de Santandersoporte@metabiblioteca.comTGljZW5jaWEgZGUgUHVibGljYWNpw7NuIFVERVMKRGlyZWN0cmljZXMgZGUgVVNPIHkgQUNDRVNPCgo=